The Use of Botulinum Toxin A in Perioral Rejuvenation

Facial Plastic Surgery Clinics of North America

Volumn 15, Issue 4, 2007, Pages 415-421

  Kaplan, Seth E ^a   Sherris, David A ^a   Gassner, Holger G ^b,c   Friedman, Oren ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; BOTULINUM TOXIN A; LIDOCAINE; PLACEBO; VASOCONSTRICTOR AGENT;

ADJUVANT THERAPY; CLINICAL TRIAL; DRUG ABSORPTION; DRUG DIFFUSION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FACE; FACE ASYMMETRY; FACE INJURY; FACE SURGERY; HUMAN; LIP; MOUTH; REVIEW; WOUND HEALING;

BOTULINUM TOXIN TYPE A; CHIN; CICATRIX; FACIAL INJURIES; HUMANS; HYPERKINESIS; MOUTH; NEUROMUSCULAR AGENTS; SKIN AGING;

EID: 36048978698     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2007.07.001     Document Type: Review

References (18)

1. Lam S. The basic concept of botulinum toxin. Facial Plast Surg Clin N Am 11 (2003) 431-438
2. Sherris D.A., Larrabee Jr. W.F., and Murakami C.S. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 28 (1995) 1057-1068
3. Armstrong M.W., Mountain R.E., and Murray J.A. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following nerve palsy. Clin Otolaryngol 21 (1996) 15-20
4. Hallet M. One man's poison-clinical applications of botulinum toxin. N Engl J Med 341 2 (1999) 118-120
5. Lovice D. Botulinum toxin use in facial plastic surgery. Otolaryngol Clin North Am 35 1 (2002) 171-186
6. Blitzer A., Binder W.F., Aviv J.E., et al. The management of hyperfunctional facial lines with botulinum toxin: a collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 123 (1997) 389-392
7. Gassner H.G., and Sherris D.A. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study. Mayo Clin Proc 75 (2000) 701-704
8. Moore K.L., and Dalley A.F. Clinically oriented anatomy. 5th edition (2006), Lippincott Williams and Wilkins, Baltimore (MD) p. 934-6
9. Loos B.M., and Maas C.S. Relevant anatomy for botulinum toxin facial rejuvenation. Facial Plast Surg Clin N Am 11 (2003) 439-443
10. Carruthers J., and Carruthers A. Botulinum toxin (Botox) chemodenervation for facial rejuvenation. Facial Plast Surg Clin N Am 9 2 (2001) 197-204
11. Fagien S. Botox for the treatment of dynamic and hyperkinetic lines and furrows: adjunctive uses in facial anesthetic surgery. Plast Reconstr Surg 103 2 (1999) 701-713
12. Carruthers J., and Carruthers A. Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg 29 5 (2003) 468-476
13. Lebwohl M., Lebwohl E., and Bercovitch L. Prominent mental (chin) creases: a new sign of Pseudoxanthoma Elasticum. J Am Acad Dermatol 48 4 (2003) 620-622
14. Stupak H.D., and Maas C.S. New procedures in facial plastic surgery using botulinum toxin A. Facial Plast Surg Clin N Am 11 (2003) 515-520
15. Sherris D.A., and Gassner H.G. Botulinum toxin to minimize facial scarring. Facial Plast Surg 18 1 (2002) 35-39
16. Gassner H.G., Brissett A.E., Otley C.C., et al. Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc 81 8 (2006) 1023-1028
17. Gassner HG, Friedman O, Sherris DA. Botulinum toxin A induced immobilization of peri-oral wounds. Presented at the 9th International Symposium of Facial Plastic Surgery. Las Vegas (NV), May 1-4, 2006.
18. Tollefson T.T., Senders C.M., Sykes J.M., et al. Botulinum toxin to improve results in cleft lip repair. Arch Facial Plast Surg 8 (2006) 221-222